Total results2,176
Search criteria
All records
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.70High >= 0.60Medium >= 0.40Low >= 0.30| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| ARHG6 | Q15052 | Rho guanine nucleotide exchange factor 6 (Alpha-Pix) (COOL-2) (PAK-interacting exchange factor alpha) (Rac/Cdc42 guanine nucleotide exchange factor 6) | Cancer-related genesPredicted intracellular proteins | Receptor-signaling mediation | 5 | 0.53 | ||||
| ARL4C | P56559 | ADP-ribosylation factor-like protein 4C (ADP-ribosylation factor-like protein 7) (ADP-ribosylation factor-like protein LAK) | Predicted intracellular proteins | Receptor-signaling mediation | 5 | 0.53 | ||||
| ARRB2 | P32121 | Beta-arrestin-2 (Arrestin beta-2) (Non-visual arrestin-3) | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 5 | 0.53 | |||||
| CCYL1 | Q8N7R7 | Cyclin-Y-like protein 1 | Predicted intracellular proteins | Receptor-signaling mediation | 5 | 0.53 | ||||
| CD1D | P15813 | Antigen-presenting glycoprotein CD1d (R3G1) (CD antigen CD1d) | Cancer-related genesCD markersPredicted membrane proteins | 1 | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 5 | 0.53 | |||
| CD33 | P20138 | Myeloid cell surface antigen CD33 (Sialic acid-binding Ig-like lectin 3) (Siglec-3) (gp67) (CD antigen CD33) | CD markersFDA approved drug targetsPlasma proteins | 1 | Acute myeloid leukaemiaAlzheimer diseaseBCR-ABL1-negative chronic myeloid leukaemia | Clinical-translation mediationFusion and delivery mediationImmune mediation | 5 | 0.53 | ||
| CD36 | P16671 | Platelet glycoprotein 4 (Fatty acid translocase) (FAT) (Glycoprotein IIIb) (GPIIIB) (Leukocyte differentiation antigen CD36) (PAS IV) (PAS-4) (Platelet collagen receptor) (Platelet glycoprotein IV) (GPIV) (Thrombospondin receptor) (CD antigen CD36) | Cancer-related genesCD markersDisease related genes | 2 | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 5 | 0.53 | |||
| CD4 | P01730 | T-cell surface glycoprotein CD4 (T-cell surface antigen T4/Leu-3) (CD antigen CD4) | CD markersDisease related genesFDA approved drug targets | 1 | Acute myeloid leukaemiaAsthmaHuman immunodeficiency virus disease | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 5 | 0.53 | ||
| CD59 | P13987 | CD59 glycoprotein (1F5 antigen) (20 kDa homologous restriction factor) (HRF-20) (HRF20) (MAC-inhibitory protein) (MAC-IP) (MEM43 antigen) (Membrane attack complex inhibition factor) (MACIF) (Membrane inhibitor of reactive lysis) (MIRL) (Protectin) (CD antigen CD59) | Cancer-related genesCD markersDisease related genes | Hereditary hemolytic anemiaMacular degenerationRetinopathy | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 5 | 0.53 | |||
| CD86 | P42081 | T-lymphocyte activation antigen CD86 (Activation B7-2 antigen) (B70) (BU63) (CTLA-4 counter-receptor B7.2) (FUN-1) (CD antigen CD86) | CD markersFDA approved drug targetsPredicted intracellular proteins | 1 | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 5 | 0.53 |